Companies: 10,795·Total market cap: $144.5T
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

WSTNYSEHealthcare● Active
$319.75
+$5.25(+1.67%)
Market Cap$22.6B
P/E Ratio
52W High$330.88
52W Low$206.8
Overview

West Pharmaceutical Services, Inc. (WST) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · WST · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$0.79B$0.48B$0.85B$0.89B$0.76B
Net Receivables$0.57B$0.55B$0.51B$0.51B$0.49B
Inventory$0.44B$0.38B$0.43B$0.41B$0.38B
Total Current Assets$1.98B$1.54B$1.94B$1.92B$1.74B
PP&E Net$0.00B$1.69B$1.51B$1.26B$1.13B
Goodwill$0.11B$0.11B$0.11B$0.11B$0.11B
Intangible Assets$0.01B$0.01B$0.02B$0.02B$0.02B
Total Assets$4.27B$3.64B$3.83B$3.62B$3.31B
Liabilities
Short-Term Debt$0.02B$0.02B$0.13B$0.00B$0.04B
Accounts Payable$0.25B$0.24B$0.24B$0.22B$0.23B
Total Current Liabilities$0.65B$0.55B$0.67B$0.52B$0.59B
Long-Term Debt$0.30B$0.20B$0.07B$0.21B$0.21B
Total Liabilities$1.09B$0.96B$0.95B$0.93B$0.98B
Stockholders Equity
Retained Earnings$4.37B$3.96B$3.52B$2.99B$2.46B
Total Stockholders Equity$3.18B$2.68B$2.88B$2.68B$2.34B
Total Liab & Equity(computed)$4.27B$3.64B$3.83B$3.62B$3.31B
Debt Summary
Total Debt$0.42B$0.31B$0.31B$0.32B$0.33B
Net Debt($0.37B)($0.18B)($0.54B)($0.58B)($0.44B)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more West Pharmaceutical Services, Inc. data

About West Pharmaceutical Services, Inc. (WST) Balance Sheet

West Pharmaceutical Services, Inc. (WST) balance sheet shows total assets of $4.27B with cash of $0.79B. Total liabilities are $1.09B, total debt $0.42B, and stockholders equity $3.18B.

Frequently asked questions

WST · 4 questions

West Pharmaceutical Services, Inc. has total debt of $0.42B with net debt of ($0.37B).

WST total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10